In-Silico Structure Database (LMISSD)

Back
Overview
Browse
Search

LMISSD: Sum Composition Results

Abbreviation Formula Mass Main Class Sub Class
Galα1-3Galβ1-3GalNAcβ1-4Galβ1-4Glcβ-Cer 44:2;O2 C76H138N2O28 1526.943620 Neutral glycosphingolipids [SP05] GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503]
Galα1-3Galβ1-3GalNAcβ1-4Galβ1-4Glcβ-Cer 44:1;O2 C76H140N2O28 1528.959270 Neutral glycosphingolipids [SP05] GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503]
Galα1-3(Fucα1-2)Galβ1-3GalNAcβ1-4Galβ1-4Glcβ-Cer 34:1;O2 C72H130N2O32 1534.860680 Neutral glycosphingolipids [SP05] GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503]
GalNAcβ1-3Galβ1-3GalNAcβ1-4Galβ1-4Glcβ-Cer 42:2;O2 C76H137N3O28 1539.938869 Neutral glycosphingolipids [SP05] GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503]
GalNAcβ1-4(Galβ1-4GlcNAcβ1-3)Galβ1-4Glcβ-Cer 42:2;O2 C76H137N3O28 1539.938869 Neutral glycosphingolipids [SP05] GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503]
GlcNAcβ1-3Galβ1-3GalNAcβ1-4Galβ1-4Glcβ-Cer 42:2;O2 C76H137N3O28 1539.938869 Neutral glycosphingolipids [SP05] GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503]
GalNAcβ1-3Galβ1-3GalNAcβ1-4Galβ1-4Glcβ-Cer 42:1;O2 C76H139N3O28 1541.954519 Neutral glycosphingolipids [SP05] GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503]
GalNAcβ1-4(Galβ1-4GlcNAcβ1-3)Galβ1-4Glcβ-Cer 42:1;O2 C76H139N3O28 1541.954519 Neutral glycosphingolipids [SP05] GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503]
GlcNAcβ1-3Galβ1-3GalNAcβ1-4Galβ1-4Glcβ-Cer 42:1;O2 C76H139N3O28 1541.954519 Neutral glycosphingolipids [SP05] GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503]
Galα1-3(Fucα1-2)Galβ1-3GalNAcβ1-4Galβ1-4Glcβ-Cer 36:1;O2 C74H134N2O32 1562.891980 Neutral glycosphingolipids [SP05] GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503]
GalNAcβ1-3Galβ1-3GalNAcβ1-4Galβ1-4Glcβ-Cer 44:2;O2 C78H141N3O28 1567.970169 Neutral glycosphingolipids [SP05] GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503]
GalNAcβ1-4(Galβ1-4GlcNAcβ1-3)Galβ1-4Glcβ-Cer 44:2;O2 C78H141N3O28 1567.970169 Neutral glycosphingolipids [SP05] GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503]
GlcNAcβ1-3Galβ1-3GalNAcβ1-4Galβ1-4Glcβ-Cer 44:2;O2 C78H141N3O28 1567.970169 Neutral glycosphingolipids [SP05] GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503]
GalNAcβ1-3Galβ1-3GalNAcβ1-4Galβ1-4Glcβ-Cer 44:1;O2 C78H143N3O28 1569.985819 Neutral glycosphingolipids [SP05] GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503]
GalNAcβ1-4(Galβ1-4GlcNAcβ1-3)Galβ1-4Glcβ-Cer 44:1;O2 C78H143N3O28 1569.985819 Neutral glycosphingolipids [SP05] GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503]
GlcNAcβ1-3Galβ1-3GalNAcβ1-4Galβ1-4Glcβ-Cer 44:1;O2 C78H143N3O28 1569.985819 Neutral glycosphingolipids [SP05] GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503]
Fucα1-3GlcNAcβ1-3Galβ1-3GalNAcβ1-4Galβ1-4Glcβ-Cer 34:1;O2 C74H133N3O32 1575.887229 Neutral glycosphingolipids [SP05] GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503]
Galα1-3(Fucα1-2)Galβ1-3GalNAcβ1-4Galβ1-4Glcβ-Cer 38:1;O2 C76H138N2O32 1590.923280 Neutral glycosphingolipids [SP05] GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503]
GalNAcβ1-3Galα1-3Galβ1-3GalNAcβ1-4Galβ1-4Glcβ-Cer 34:1;O2 C74H133N3O33 1591.882144 Neutral glycosphingolipids [SP05] GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503]
GalNAcβ1-4(Galα1-3Galβ1-4GlcNAcβ1-3)Galβ1-4Glcβ-Cer 34:1;O2 C74H133N3O33 1591.882144 Neutral glycosphingolipids [SP05] GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503]
Galβ1-4GalNAcβ1-3Galβ1-3GalNAcβ1-4Galβ1-4Glcβ-Cer 34:1;O2 C74H133N3O33 1591.882144 Neutral glycosphingolipids [SP05] GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503]
Galβ1-4GlcNAcβ1-3Galβ1-3GalNAcβ1-4Galβ1-4Glcβ-Cer 34:1;O2 C74H133N3O33 1591.882144 Neutral glycosphingolipids [SP05] GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503]
Fucα1-3GlcNAcβ1-3Galβ1-3GalNAcβ1-4Galβ1-4Glcβ-Cer 36:1;O2 C76H137N3O32 1603.918529 Neutral glycosphingolipids [SP05] GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503]
Galα1-3(Fucα1-2)Galβ1-3GalNAcβ1-4Galβ1-4Glcβ-Cer 40:1;O2 C78H142N2O32 1618.954580 Neutral glycosphingolipids [SP05] GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503]
GalNAcβ1-3Galα1-3Galβ1-3GalNAcβ1-4Galβ1-4Glcβ-Cer 36:1;O2 C76H137N3O33 1619.913444 Neutral glycosphingolipids [SP05] GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503]
GalNAcβ1-4(Galα1-3Galβ1-4GlcNAcβ1-3)Galβ1-4Glcβ-Cer 36:1;O2 C76H137N3O33 1619.913444 Neutral glycosphingolipids [SP05] GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503]
Galβ1-4GalNAcβ1-3Galβ1-3GalNAcβ1-4Galβ1-4Glcβ-Cer 36:1;O2 C76H137N3O33 1619.913444 Neutral glycosphingolipids [SP05] GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503]
Galβ1-4GlcNAcβ1-3Galβ1-3GalNAcβ1-4Galβ1-4Glcβ-Cer 36:1;O2 C76H137N3O33 1619.913444 Neutral glycosphingolipids [SP05] GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503]
Fucα1-3GlcNAcβ1-3Galβ1-3GalNAcβ1-4Galβ1-4Glcβ-Cer 38:1;O2 C78H141N3O32 1631.949829 Neutral glycosphingolipids [SP05] GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503]
Galα1-3(Fucα1-2)Galβ1-3GalNAcβ1-4Galβ1-4Glcβ-Cer 42:2;O2 C80H144N2O32 1644.970230 Neutral glycosphingolipids [SP05] GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503]
Galα1-3(Fucα1-2)Galβ1-3GalNAcβ1-4Galβ1-4Glcβ-Cer 42:1;O2 C80H146N2O32 1646.985880 Neutral glycosphingolipids [SP05] GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503]
GalNAcβ1-3Galα1-3Galβ1-3GalNAcβ1-4Galβ1-4Glcβ-Cer 38:1;O2 C78H141N3O33 1647.944744 Neutral glycosphingolipids [SP05] GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503]
GalNAcβ1-4(Galα1-3Galβ1-4GlcNAcβ1-3)Galβ1-4Glcβ-Cer 38:1;O2 C78H141N3O33 1647.944744 Neutral glycosphingolipids [SP05] GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503]
Galβ1-4GalNAcβ1-3Galβ1-3GalNAcβ1-4Galβ1-4Glcβ-Cer 38:1;O2 C78H141N3O33 1647.944744 Neutral glycosphingolipids [SP05] GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503]
Galβ1-4GlcNAcβ1-3Galβ1-3GalNAcβ1-4Galβ1-4Glcβ-Cer 38:1;O2 C78H141N3O33 1647.944744 Neutral glycosphingolipids [SP05] GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503]
Fucα1-3GlcNAcβ1-3Galβ1-3GalNAcβ1-4Galβ1-4Glcβ-Cer 40:1;O2 C80H145N3O32 1659.981129 Neutral glycosphingolipids [SP05] GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503]
Galα1-3(Fucα1-2)Galβ1-3GalNAcβ1-4Galβ1-4Glcβ-Cer 44:2;O2 C82H148N2O32 1673.001530 Neutral glycosphingolipids [SP05] GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503]
Galα1-3(Fucα1-2)Galβ1-3GalNAcβ1-4Galβ1-4Glcβ-Cer 44:1;O2 C82H150N2O32 1675.017180 Neutral glycosphingolipids [SP05] GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503]
GalNAcβ1-3Galα1-3Galβ1-3GalNAcβ1-4Galβ1-4Glcβ-Cer 40:1;O2 C80H145N3O33 1675.976044 Neutral glycosphingolipids [SP05] GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503]
GalNAcβ1-4(Galα1-3Galβ1-4GlcNAcβ1-3)Galβ1-4Glcβ-Cer 40:1;O2 C80H145N3O33 1675.976044 Neutral glycosphingolipids [SP05] GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503]
Galβ1-4GalNAcβ1-3Galβ1-3GalNAcβ1-4Galβ1-4Glcβ-Cer 40:1;O2 C80H145N3O33 1675.976044 Neutral glycosphingolipids [SP05] GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503]
Galβ1-4GlcNAcβ1-3Galβ1-3GalNAcβ1-4Galβ1-4Glcβ-Cer 40:1;O2 C80H145N3O33 1675.976044 Neutral glycosphingolipids [SP05] GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503]
Fucα1-3GlcNAcβ1-3Galβ1-3GalNAcβ1-4Galβ1-4Glcβ-Cer 42:2;O2 C82H147N3O32 1685.996779 Neutral glycosphingolipids [SP05] GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503]
Fucα1-3GlcNAcβ1-3Galβ1-3GalNAcβ1-4Galβ1-4Glcβ-Cer 42:1;O2 C82H149N3O32 1688.012429 Neutral glycosphingolipids [SP05] GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503]
GalNAcβ1-3Galα1-3Galβ1-3GalNAcβ1-4Galβ1-4Glcβ-Cer 42:2;O2 C82H147N3O33 1701.991694 Neutral glycosphingolipids [SP05] GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503]
GalNAcβ1-4(Galα1-3Galβ1-4GlcNAcβ1-3)Galβ1-4Glcβ-Cer 42:2;O2 C82H147N3O33 1701.991694 Neutral glycosphingolipids [SP05] GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503]
Galβ1-4GalNAcβ1-3Galβ1-3GalNAcβ1-4Galβ1-4Glcβ-Cer 42:2;O2 C82H147N3O33 1701.991694 Neutral glycosphingolipids [SP05] GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503]
Galβ1-4GlcNAcβ1-3Galβ1-3GalNAcβ1-4Galβ1-4Glcβ-Cer 42:2;O2 C82H147N3O33 1701.991694 Neutral glycosphingolipids [SP05] GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503]
GalNAcβ1-3Galα1-3Galβ1-3GalNAcβ1-4Galβ1-4Glcβ-Cer 42:1;O2 C82H149N3O33 1704.007344 Neutral glycosphingolipids [SP05] GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503]
GalNAcβ1-4(Galα1-3Galβ1-4GlcNAcβ1-3)Galβ1-4Glcβ-Cer 42:1;O2 C82H149N3O33 1704.007344 Neutral glycosphingolipids [SP05] GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503]